TITLE

Dually Eligible Enrollees: 2002

AUTHOR(S)
Lied, Terry R.
PUB. DATE
June 2006
SOURCE
Health Care Financing Review;Summer2006, Vol. 27 Issue 4, p137
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
Individuals eligible in both Medicaid and Medicare, the dually eligible enrollees, account for a disproportionate share of Medicaid utilization and payments. While comprising 14.7 percent of the Medicaid population, they accounted for 40.5 percent of Medicaid payments in 2002. Mean reimbursement for the dually eligible enrollees was nearly four times that of non-dually eligible Medicaid enrollees. This highlight examines utilization and payment data for the dually eligible enrollees in 2002.
ACCESSION #
22291655

 

Related Articles

  • Medicare And Medicaid Programs.  // Congressional Digest;Apr87, Vol. 66 Issue 4, p100 

    Focuses on the Medicare and Medicaid health insurance programs of the U.S. Years of creation of the programs; Eligibility for the Medicare health insurance program; Types of health services covered by the Medicaid program.

  • A look at the new, improved(?) American healthcare system. Howard, Ed // Generations;Summer96, Vol. 20 Issue 2, p5 

    Looks at the changes in the Medicare and Medicaid programs of the United States. Impact of balancing of federal budget on healthcare programs; Reductions in proposed cutbacks in Medicare and Medicaid; Issue on the role of the government in paying for or regulating healthcare.

  • Coordinating Care for the Dual-Eligible Population. Ripley, Jeanne // hfm (Healthcare Financial Management);Jun2001, Vol. 55 Issue 6, p39 

    Deals with the coordination of funding for dual-eligible individuals who qualify for Medicare and Medicaid in the United States. Problems of dual financing; Implementation of pilot programs to bring together Medicare and Medicaid financing streams; Information on Minnesota's Senior Health...

  • Ins. covers Medicare, Medicaid compliance. Gjertsen, Lee Ann // National Underwriter / Property & Casualty Risk & Benefits Manag;08/31/98, Vol. 102 Issue 35, p19 

    Focuses on an insurance program developed by J&H Marsh & McLennan which included the coverage of Medicare and Medicaid compliance. Mitigation of unintentional violations; Coverage up to $50 million; Support of the insurance program by the company's tight network of health care professionals.

  • Why Life Extension's Pharmacy is Unique. La Corte, Frank // Life Extension;Mar2009, Vol. 15 Issue 3, p81 

    The article provides information on Life Extension Pharmacy in the U.S. It states that Life Extension Pharmacy welcomes the insurance plans including Medicare Part D, Florida Medicaid, and worker's compensation. Accordingly, the pharmacy operates Monday to Friday from 9:00 a.m. to 8:00 p.m., and...

  • Weigh in on budget.  // AHA News;3/11/2002, Vol. 38 Issue 9, p4 

    Editorial. Comments on the Medicare and Medicaid budget in the U.S. Role of the Congress in the debate over Medicare/Medicaid budget.

  • Medicaid 'Very Important' to Americans.  // State News (Council of State Governments);Aug2005, Vol. 48 Issue 7, p9 

    Presents the result of a survey on the attitude of the U.S. public towards Medicaid. Percentage of survey respondents who believe that Medicaid is an important government program; Belief that the federal government should maintain federal spending on Medicaid; Findings that Medicaid ranks...

  • How to Stop The HIPAA Clock. Black, Amy // Review of Optometry;7/15/2002, Vol. 139 Issue 7, p29 

    Reports on key issues and developments relevant to the Health Insurance Portability and Accountability Act in the U.S. Implications for optometric practices; Centers for medicare and medicaid services; Implications for medical care. INSET: Help with HIPAA: Where to Go.

  • Should CMS limit reimbursement to rate for off-label alternative?  // PharmacoEconomics & Outcomes News;9/17/2011, Issue 637, p3 

    The article reports that U.S. Medicare may have saved 1.1 billion dollars between 2008 and 2009 if all its beneficiaries with wet age-related macular degeneration (wet AMD) were treated with the Avastatin (bevacizumab) rate, as Lucentis (ranibizumab) is more expensive.

  • BAD month.  // McKnight's Long-Term Care News;Jul2010, Vol. 31 Issue 7, p14 

    The article offers updates related to health insurance in the U.S. for July 2010, including the determination of Medicare payments after the new Minimum Data Set (MDS 3.0) and the plan to implement Medicaid payment cuts due to budget crisis.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics